FinZonalExplore Data →
← CompaniesCOMPANY FINANCIAL PROFILE

ELI LILLY & Co

LLY · CIK 0000059478 · Pharmaceutical Preparations

Last SEC sync: Nov 7, 2026 01:03 UTC

About ELI LILLY & Co

Eli Lilly and Company (referred to as the company, Lilly, we, or us) was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly.

Business information sourced from SEC annual filing filed Feb 12, 2026. Business descriptions reflect the cited filing and may not describe subsequent changes.

Company identification is based on SEC registration information. Financial figures are sourced from SEC filings.

Financial highlights

Latest qualifying annual SEC observations · USD
Revenue$65.18BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 12, 2026
Net Income$20.64BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 12, 2026
Operating Income—Not available
Total Assets$112.48BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 12, 2026
Total Liabilities—Not available
Cash and Cash Equivalents$7.27BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 12, 2026
Operating Cash Flow$16.81BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 12, 2026
Revenue growth · latest comparable annual periods44.7%
Net profit margin · matching fiscal period31.7%

Historical financial performance

USD billions · Annual SEC observations · Choose a metric

Each metric uses a consistent SEC accounting concept when available. Fiscal year-end dates may differ across metrics. Negative values are displayed with a minus sign.

Annual financial history

USD · Exact fiscal period ends
Period endedRevenueNet incomeOperating incomeAssetsLiabilitiesCashOperating cash flowNet margin
Dec. 31, 2025$65.18B$20.64B—$112.48B—$7.27B$16.81B31.7%
Dec. 31, 2024$45.04B$10.59B—$78.72B—$3.27B$8.82B23.5%
Dec. 31, 2023$34.12B$5.24B—$64.01B—$2.82B$4.24B15.4%
Dec. 31, 2022$28.54B$6.24B—$49.49B—$2.07B$7.59B21.9%
Dec. 31, 2021$28.32B$5.58B—$48.81B—$3.82B$7.37B19.7%
Dec. 31, 2020$24.54B$6.19B—$46.63B—$3.66B$6.50B25.2%
Dec. 31, 2019$22.32B$8.32B—$39.29B—$2.34B$4.84B37.3%
Dec. 31, 2018$21.49B$3.23B—$43.91B—$7.32B$5.52B15.0%

A dash indicates unavailable or nonmatching period data. Figures are SEC observations, not estimates.

Company information

Registered name
ELI LILLY & Co
Ticker symbol
LLY
CIK
0000059478
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC SIC code
2834
Fiscal year end (MMDD)
1231
Last SEC synchronization
Nov 7, 2026 01:03 UTC
Headquarters / business address
LILLY CORPORATE CTR
DROP CODE 1094
INDIANAPOLIS, IN 46285
Mailing address
LILLY CORPORATE CENTER
DROP CODE 1094
INDIANAPOLIS, IN 46285
Business phone
3172762000

Company contact information is drawn from SEC submissions, where reported, and may not reflect current operating locations. Last company information check: Nov 7, 2026 20:21 UTC. Official website, business descriptions and executive details require separate verification.

Latest SEC filings

Browse filings →
FormFiledReport periodOfficial source
8-KOct. 29, 2026Oct. 29, 2026View SEC filing ↗
8-KAug. 5, 2026Aug. 5, 2026View SEC filing ↗
8-KMay 20, 2026May 20, 2026View SEC filing ↗
8-KMay 7, 2026May 4, 2026View SEC filing ↗
8-KApril 30, 2026April 30, 2026View SEC filing ↗
8-KFeb. 4, 2026Feb. 4, 2026View SEC filing ↗
8-KNov. 21, 2025Nov. 18, 2025View SEC filing ↗
8-KOct. 30, 2025Oct. 30, 2025View SEC filing ↗
8-KAug. 20, 2025Aug. 18, 2025View SEC filing ↗
8-KAug. 7, 2025Aug. 7, 2025View SEC filing ↗
8-KMay 8, 2025May 5, 2025View SEC filing ↗
8-KMay 1, 2025May 1, 2025View SEC filing ↗
8-KFeb. 12, 2025Feb. 10, 2025View SEC filing ↗
8-KFeb. 6, 2025Feb. 6, 2025View SEC filing ↗
8-KJan. 14, 2025Jan. 14, 2025View SEC filing ↗
8-KNov. 19, 2024Nov. 19, 2024View SEC filing ↗
8-KOct. 30, 2024Oct. 30, 2024View SEC filing ↗
8-KSept. 9, 2024Sept. 5, 2024View SEC filing ↗
8-KAug. 16, 2024Aug. 13, 2024View SEC filing ↗
8-KAug. 14, 2024Aug. 12, 2024View SEC filing ↗

Financial data is provided for informational purposes, not investment advice. Observations may include restatements; review original SEC filings before making decisions.